Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Boehringer Ingelheim Cyltezo gets USFDA nod as 1st iterchangeable biosimilar with Humira

Ruchika Sharma17 Oct 2021 11:00 AM IST

Ridgefield: Boehringer Ingelheim has recently announced that the U.S. Food and Drug Administration (USFDA) has approved the supplemental Biologics...

Pfizer-BioNTech seek EU agency nod for COVID vaccines for kids 5-11

Ruchika Sharma17 Oct 2021 10:00 AM IST

Berlin : Pharmaceutical company Pfizer and biotechnology company BioNTech informed they have requested to have their coronavirus vaccine licensed for...

Govt lifts export curbs on diagnostic kits, reagents

Ruchika Sharma17 Oct 2021 10:00 AM IST

New Delhi: With COVID-19 cases coming down in the country, the government on Friday removed export curbs on all diagnostic kits and reagents including...

Roche gets USFDA okay for cancer treatment Tecentriq

Ruchika Sharma16 Oct 2021 4:30 PM IST

Basel: Roche has recently announced that the US Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) as adjuvant treatment,...

Dr Reddys launches Carmustine for Injection in US

Ruchika Sharma16 Oct 2021 3:16 PM IST

Hyderabad: Pharma major, Dr Reddy's Laboratories Ltd., has recently announced the launch of Carmustine for Injection, USP.The product is a therapeutic...

Will ask experts to scrutinize Merck Covid-19 pill in late November: FDA

Ruchika Sharma16 Oct 2021 1:05 PM IST

Washington: The Food and Drug Administration said Thursday it will ask its outside experts to meet in late November to scrutinize Merck's pill to...

Abbott Labs unit recalls 2 COVID lab test kits over false positive results

Ruchika Sharma16 Oct 2021 1:00 PM IST

An overflow of one patient sample into another while mixing chemicals with the samples could be related to the false positive results, the FDA said on...

India resumes Covid-19 vaccine exports

Ruchika Sharma16 Oct 2021 11:51 AM IST

New Delhi: India has resumed a small amount of exports of Covid-19 vaccines and will increase exports significantly in the next few months as domestic...

Purdue Pharma judge rejects call to halt opioid deal

Ruchika Sharma15 Oct 2021 10:15 AM IST

New Delhi: Purdue Pharma has defeated a request to pause the implementation of its reorganization plan that provides legal protections to the Sackler...

New toxic drug impurities detected in some heart pills in US: Bloomberg

Ruchika Sharma15 Oct 2021 9:15 AM IST

New Delhi: Over the past three years, millions of blood pressure pills that contain a probable carcinogen have been recalled around the world. As...

Proteon Pharma to focus on Bacteriophages development as aternative to antibiotics in poultry industry

Ruchika Sharma15 Oct 2021 9:00 AM IST

Mumbai: Proteon Pharmaceuticals India, a subsidiary of Proteon Pharmaceuticals SA Poland, has recently announced that the company will focus...

Analysis of JnJ COVID booster data by USFDA scientists raises red flags

Ruchika Sharma14 Oct 2021 12:30 PM IST

US: U.S. Food and Drug Administration scientists said on Wednesday they did not receive enough data in time to do their own analysis of Johnson &...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok